Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
暂无分享,去创建一个
David J. Abraham | Christopher P. Denton | D. Abraham | C. Denton | P. Sestini | E. Renzoni | E. Weber | Piersante Sestini | Elisabetta Weber | Antonella Rossi | Francesca Sozio | Elisabetta A. Renzoni | Korsa Khan | A. Rossi | K. Khan | F. Sozio
[1] Paul C. Gorski. The Myth , 2022, Nkrumah and the Ghana Revolution.
[2] J. Seibold,et al. Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin". , 2010, Arthritis and rheumatism.
[3] B. Mehrara,et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. , 2008, American journal of physiology. Heart and circulatory physiology.
[4] A. Herrick,et al. High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis. , 2008, Rheumatology.
[5] R. Gomer. Circulating progenitor cells and scleroderma , 2008, Current rheumatology reports.
[6] Hiroshi I. Suzuki,et al. Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. , 2008, Blood.
[7] S. Schwartz,et al. The pathology of scleroderma vascular disease. , 2008, Rheumatic diseases clinics of North America.
[8] B. Kahaleh. Vascular disease in scleroderma: mechanisms of vascular injury. , 2008, Rheumatic diseases clinics of North America.
[9] M. Simons,et al. Vascular disease in scleroderma: angiogenesis and vascular repair. , 2008, Rheumatic diseases clinics of North America.
[10] Stephen M. Schwartz,et al. Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype? , 2008, PloS one.
[11] J. Chung,et al. Reduction of lymphatic vessels in photodamaged human skin. , 2007, Journal of dermatological science.
[12] D. Abraham,et al. How does endothelial cell injury start? The role of endothelin in systemic sclerosis , 2007, Arthritis research & therapy.
[13] P. Helmbold,et al. Radiogenic lymphangiogenesis in the skin. , 2007, The American journal of pathology.
[14] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.
[15] David Abraham,et al. Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.
[16] Brady T. West,et al. Linear Mixed Models: A Practical Guide Using Statistical Software , 2006 .
[17] M. Detmar,et al. New insights into the molecular control of the lymphatic vascular system and its role in disease. , 2006, The Journal of investigative dermatology.
[18] A. Gabrielli,et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. , 2006, Arthritis and rheumatism.
[19] Meit A. Bjorndahl,et al. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. , 2005, Blood.
[20] M. Detmar,et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. , 2005, The American journal of pathology.
[21] D. Hicklin,et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. , 2004, Blood.
[22] Y. Ikeda,et al. Defective vasculogenesis in systemic sclerosis , 2004, The Lancet.
[23] Till Acker,et al. Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis , 2004, Circulation research.
[24] P. Qu,et al. Expression of VEGFR‐3 and 5′‐Nase in regenerating lymphatic vessels of the cutaneous wound healing , 2004, Microscopy research and technique.
[25] A Sulli,et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. , 2004, Rheumatology.
[26] H. Takiwaki,et al. Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases. , 2004, Journal of the American Academy of Dermatology.
[27] T. Ryan. The ageing of the blood supply and the lymphatic drainage of the skin. , 2004, Micron.
[28] Shin-Seok Lee,et al. Elevated vascular endothelial growth factor in systemic sclerosis. , 2003, The Journal of rheumatology.
[29] Y. Konttinen,et al. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. , 2002, Clinical and experimental rheumatology.
[30] Alexander Marks,et al. A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors , 2002, Laboratory Investigation.
[31] M. Conforti,et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers , 2002, Arthritis research.
[32] P. Carmeliet,et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy , 2002, The EMBO journal.
[33] G. Strutton,et al. Cutaneous histiocytic lymphangitis: An unusual manifestation of rheumatoid arthritis , 2000, The Australasian journal of dermatology.
[34] J. Isner,et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.
[35] P. Bruehlmann,et al. Lymphatic microangiopathy of the skin in systemic sclerosis. , 1999, Rheumatology.
[36] E. Leroy. SYSTEMIC SCLEROSIS : A Vascular Perspective , 1996 .
[37] C. Kallenberg,et al. Early detection of connective tissue disease in patients with Raynaud's phenomenon. , 1990, Rheumatic diseases clinics of North America.
[38] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[39] Geert Molenberghs,et al. Linear Mixed Models , 2011, International Encyclopedia of Statistical Science.
[40] Y. Konttinen,et al. Variations of neuronal nitric oxide synthase in systemic sclerosis skin. , 2006, Arthritis and rheumatism.
[41] R. Scorza,et al. Assessment of vascular involvement. , 2003, Clinical and experimental rheumatology.
[42] A. Damião,et al. Protein-losing enteropathy in systemic lupus erythematosus. , 1991, Revista do Hospital das Clinicas.